Fereshteh Abbasvandi

797 total citations
43 papers, 527 citations indexed

About

Fereshteh Abbasvandi is a scholar working on Biomedical Engineering, Oncology and Cancer Research. According to data from OpenAlex, Fereshteh Abbasvandi has authored 43 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Biomedical Engineering, 10 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Fereshteh Abbasvandi's work include Microfluidic and Bio-sensing Technologies (8 papers), Cancer Cells and Metastasis (5 papers) and 3D Printing in Biomedical Research (5 papers). Fereshteh Abbasvandi is often cited by papers focused on Microfluidic and Bio-sensing Technologies (8 papers), Cancer Cells and Metastasis (5 papers) and 3D Printing in Biomedical Research (5 papers). Fereshteh Abbasvandi collaborates with scholars based in Iran, United Kingdom and United States. Fereshteh Abbasvandi's co-authors include Mohammad Abdolahad, Ashkan Zandi, Mohammad Ali Khayamian, Hassan Sanati, Fatemeh Shojaeian, Ramin Sarrami‐Forooshani, Jalil Makarem, Mahsa Faramarzpour, Meisam Hoseinyazdi and Mohammad Salemizadeh Parizi and has published in prestigious journals such as Scientific Reports, Nanoscale and Biosensors and Bioelectronics.

In The Last Decade

Fereshteh Abbasvandi

41 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fereshteh Abbasvandi Iran 13 205 166 99 72 69 43 527
Chenxia Hu China 10 77 0.4× 264 1.6× 86 0.9× 31 0.4× 30 0.4× 20 667
Gaoqin Liu China 15 174 0.8× 497 3.0× 22 0.2× 54 0.8× 177 2.6× 46 1.0k
Aiqun Ma China 11 202 1.0× 356 2.1× 54 0.5× 43 0.6× 13 0.2× 29 574
Yanpu Wang China 15 312 1.5× 404 2.4× 42 0.4× 28 0.4× 116 1.7× 28 918
Xian Li China 15 130 0.6× 273 1.6× 13 0.1× 68 0.9× 54 0.8× 45 684
Su‐Ming Hsu Taiwan 15 146 0.7× 199 1.2× 31 0.3× 37 0.5× 46 0.7× 19 640
Guohong Lin China 8 168 0.8× 205 1.2× 30 0.3× 42 0.6× 11 0.2× 9 532
Wies Deckers Belgium 6 78 0.4× 336 2.0× 18 0.2× 19 0.3× 61 0.9× 11 740

Countries citing papers authored by Fereshteh Abbasvandi

Since Specialization
Citations

This map shows the geographic impact of Fereshteh Abbasvandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fereshteh Abbasvandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fereshteh Abbasvandi more than expected).

Fields of papers citing papers by Fereshteh Abbasvandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fereshteh Abbasvandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fereshteh Abbasvandi. The network helps show where Fereshteh Abbasvandi may publish in the future.

Co-authorship network of co-authors of Fereshteh Abbasvandi

This figure shows the co-authorship network connecting the top 25 collaborators of Fereshteh Abbasvandi. A scholar is included among the top collaborators of Fereshteh Abbasvandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fereshteh Abbasvandi. Fereshteh Abbasvandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Abbasvandi, Fereshteh, et al.. (2025). Tumor characteristics and survival rate of axillary metastatic breast cancer patients: a three decades retrospective cohort study. Scientific Reports. 15(1). 4571–4571. 2 indexed citations
3.
Khayamian, Mohammad Ali, Mohammad Salemizadeh Parizi, Fereshteh Abbasvandi, et al.. (2024). Breast cancer diagnostics by the intelligent analysis of white blood cells’ interaction with target cancer cells using convolutional neural networks. Microchemical Journal. 205. 111344–111344. 2 indexed citations
4.
5.
Abbasvandi, Fereshteh, et al.. (2024). The Relationship Between Upper‐Limb Lymphedema and Fatigue Among Breast Cancer Survivors. European Journal of Cancer Care. 2024(1). 1 indexed citations
6.
Abbasvandi, Fereshteh, et al.. (2024). Sleep quality and risk of obstructive sleep apnea among breast cancer survivors with and without lymphedema. Sleep And Breathing. 29(1). 41–41. 1 indexed citations
7.
Barough, Mahdieh Shokrollahi, Zahra Sadat Hashemi, Hassan Sanati, et al.. (2023). Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19. Pilot and Feasibility Studies. 9(1). 137–137. 6 indexed citations
8.
Abbasvandi, Fereshteh, et al.. (2023). Tumor characteristics and survival rate of HER2-low breast cancer patients: a retrospective cohort study. Scientific Reports. 13(1). 16719–16719. 8 indexed citations
9.
Abbasvandi, Fereshteh, et al.. (2023). Hydroelectric actuator for 3-dimensional analysis of electrophoretic and dielectrophoretic behavior of cancer cells; suitable in diagnosis and invasion studies. Biomaterials Advances. 151. 213476–213476. 23 indexed citations
10.
Abbasvandi, Fereshteh, et al.. (2023). Electrochemical therapy (EChT) of cancer tumor with an external anode, a way to achieve pathological complete response. Medical Oncology. 40(4). 117–117. 3 indexed citations
11.
Yousefi, Maryam, Fereshteh Abbasvandi, Payam Sadeghi, et al.. (2023). Primary repair with no flaps for lower lip defects (30–80 %) after cancer excision. Asian Journal of Surgery. 47(2). 995–998.
12.
Aghayan, Hamid Reza, Atefeh Abedini, Samrand Fattah Ghazi, et al.. (2022). Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment. Stem Cell Research & Therapy. 13(1). 365–365. 32 indexed citations
13.
Khayamian, Mohammad Ali, Mahsa Faramarzpour, Ashkan Zandi, et al.. (2021). Capture-free deactivation of CTCs in the bloodstream; a metastasis suppression method by electrostatic stimulation of the peripheral blood. Biosensors and Bioelectronics. 183. 113194–113194. 12 indexed citations
15.
Akbari, Mohammad Esmaeil, et al.. (2021). Electrochemical measuring of reactive oxygen species levels in the blood to detect ratio of high-density neutrophils, suitable to alarm presence of cancer in suspicious cases. Journal of Pharmaceutical and Biomedical Analysis. 209. 114488–114488. 5 indexed citations
16.
Abbasvandi, Fereshteh, et al.. (2020). Electrically guided interventional radiology, in-vivo electrochemical tracing of suspicious lesions to breast cancer prior to core needle biopsy. Biosensors and Bioelectronics. 161. 112209–112209. 10 indexed citations
17.
Sarrami‐Forooshani, Ramin, Hassan Sanati, Jalil Makarem, et al.. (2020). Real-time diagnosis of reactive oxygen species (ROS) in fresh sputum by electrochemical tracing; correlation between COVID-19 and viral-induced ROS in lung/respiratory epithelium during this pandemic. Biosensors and Bioelectronics. 165. 112435–112435. 119 indexed citations
18.
Abbasvandi, Fereshteh, et al.. (2020). Bioelectrical pathology of the breast; real-time diagnosis of malignancy by clinically calibrated impedance spectroscopy of freshly dissected tissue. Biosensors and Bioelectronics. 165. 112421–112421. 24 indexed citations
19.
Zandi, Ashkan, A. Ghanadzadeh Gilani, Fereshteh Abbasvandi, et al.. (2019). Carbon nanotube based dielectric spectroscopy of tumor secretion; electrochemical lipidomics for cancer diagnosis. Biosensors and Bioelectronics. 142. 111566–111566. 12 indexed citations
20.
Larijani, Bagher, et al.. (2002). Treatment of hyperfunctioning thyroid nodules by percutaneous ethanol injection. BMC Endocrine Disorders. 2(1). 3–3. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026